| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |